greeksoup/ stock research

Innoviva (INVA) Q1 FY2025 earnings: revenue $89 million, up 14.4% on the year

Innoviva, Inc. (INVA) reported revenue of $89 million for Q1 FY2025, the quarter ended 31 March 2025, up 14.4% on the same quarter a year earlier. Net income was -$47 million, and diluted earnings per share $-0.74. The figures are the company's own, from the 10-Q it filed with the SEC on 7 May 2025.

Revenue$89 millionup 14.4%
Net income-$47 million
Diluted EPS$-0.74
QuarterQ1 FY2025ended 31 March 2025

The quarter, against the one before and a year earlier

LineQ1 FY2025Q4 FY2024Q1 FY2024Change on the year
Revenue88.691.877.5+14.4%
Gross profit73.378.160.1+22.0%
Gross margin82.7%85.1%77.5%
Research and development4.43.73.9+13.4%
Selling, general and administrative27.531.330.4-9.6%
Operating income41.443.125.8+60.5%
Operating margin46.7%47.0%33.3%
Interest expense4.74.75.9-19.5%
Pre-tax income-38.624.745.1n/a
Income tax8.04.48.6-6.9%
Effective tax raten/a17.7%19.0%
Net income-46.620.336.5n/a
Net margin-52.6%22.1%47.1%
Diluted EPS-$0.74$0.26$0.46n/a
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ1 FY2025Q4 FY2024Q1 FY2024Change on the year
Operating cash flow48.659.237.0+31.2%
Capital expenditure0.00.00.0n/a
Free cash flow48.659.237.0+31.2%
Free cash flow margin54.9%64.5%47.8%
Cash from investing-34.7-15.5-43.0n/a
Cash from financing0.20.6-9.2n/a
Share-based compensation2.11.71.5+47.6%
Buybacks0.00.09.6n/a
Diluted shares, weighted63mn/a85m-25.8%
Shares outstanding at period end63m63m63m-0.0%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ1 FY2025Q4 FY2024Q1 FY2024Change on the year
Shareholders' equity647691704-8.1%
Debt449448447+0.5%
Operating lease liabilities1.11.21.3-16.3%
Other liabilities158160116+35.9%
Total liabilities and equity1,2541,3011,268-1.0%
Fixed assets0.50.50.3+49.1%
Goodwill17.917.917.9+0.0%
Intangible assets202208224-9.8%
Investments291342477-38.9%
Cash and equivalents319305178+78.9%
Inventory41.533.737.4+10.8%
Other assets382394333+14.8%
Total assets1,2541,3011,268-1.0%

Questions

What was Innoviva's revenue in Q1 FY2025?

Innoviva (INVA) reported revenue of $89 million for Q1 FY2025, the quarter ended 31 March 2025, up 14.4% on the same quarter a year earlier.

How much did Innoviva earn in Q1 FY2025?

Net loss for Q1 FY2025 was $47 million, and the diluted loss per share $0.74.

When did Innoviva report Q1 FY2025 results?

Innoviva filed its 10-Q for the quarter ended 31 March 2025 with the SEC on 7 May 2025.

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue67.385.877.599.989.591.888.610010811598.0120
Gross profitn/an/a60.185.073.078.173.383.175.575.775.890.6
Gross marginn/an/a78%85%82%85%83%83%70%66%77%76%
R&D4.02.43.92.63.63.74.48.013.74.65.25.2
SG&A28.626.330.427.726.231.327.526.427.332.132.434.6
Operating income86.061.225.854.743.243.141.448.834.639.038.250.9
Operating margin128%71%33%55%48%47%47%49%32%34%39%43%
Interest expense4.46.05.95.85.84.74.74.74.03.35.45.5
Pre-tax income86.061.245.1-39.36.824.7-38.672.697.8195235-108
Tax rate5%-1%19%n/a82%18%n/a12%8%16%20%n/a
Net income82.061.536.5-34.71.220.3-46.663.789.9164187-83.4
Net margin122%72%47%-35%1%22%-53%64%83%143%190%-70%
Diluted EPS$0.98$0.76$0.46-$0.55$0.02$0.26-$0.74$0.77$1.08$1.94$2.22-$1.14
Operating cash flow43.933.337.043.748.759.248.644.149.754.535.352.0
Capital expenditure0.20.20.00.00.30.00.00.01.10.00.50.4
Free cash flow43.733.137.043.748.459.248.644.148.654.534.851.5
Buybacks11.114.69.65.20.00.00.00.00.04.520.231.1
Shares outstanding64m63m63m63m63m63m63m63m75m75m74m73m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 31 March 2025, filed 7 May 2025, accession 0000950170-25-065765: the filing on EDGAR. All of Innoviva, Inc.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install